Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02415894

Enrollment

172

Registered

2015-04-14

Start date

2015-04-30

Completion date

2016-04-30

Last updated

2016-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Abortion

Brief summary

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* Having an ongoing pregnancy of 13-22 weeks gestation * Be willing to undergo surgical completion if necessary * Have no contraindications to study procedures, according to provider * Be willing and able to consent to participate in the study * Be willing to follow study procedures

Exclusion criteria

* Known allergy to mifepristone or misoprostol/prostaglandin * Any contraindications to vaginal delivery, including placenta previa * Unable to provide consent

Design outcomes

Primary

Measure	Time frame
Rate of successful abortion	15 hours after start of misoprostol induction

Countries

Ukraine

Outcome results